drugset / Trial / NCT00713791
Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.
RandomizedCrossoverSingle-blindBasic science
Summary
This study is designed to see how different formulations of ZD4054 (Zibotentan) are absorbed by the body. As for all clinical trials, safety and tolerability of the drug will be evaluated.
Timeline
- Start
- 2008-06
- Primary completion
- —
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zibotentan | Small molecule | 10 mg | Oral |
Indications
No indication recorded.